Julie Nonnekens

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib

Julie Nonnekens, Melissa van Kranenburg, Cecile Beerens et al. · Theranostics · 2016 · 137 citations · Full text

Medicine, Molecular Biology, Oncology +17

Comparison of the Therapeutic Response to Treatment with a ¹⁷⁷Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models

Simone U. Dalm, Julie Nonnekens, Gabriela N. Doeswijk et al. · Journal of Nuclear Medicine · 2015 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

Eline A. M. Ruigrok, Nicole van Vliet, Simone U. Dalm et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

Role of the DNA damage response in prostate cancer formation, progression and treatment

Wenhao Zhang, Dik C. van Gent, Luca Incrocci et al. · Prostate Cancer and Prostatic Diseases · 2019 · 76 citations · Full text

Medicine, Molecular Biology, Oncology +17

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

Kristell L.S. Chatalic, Mark Konijnenberg, Julie Nonnekens et al. · Theranostics · 2015 · 69 citations · Full text

Medicine, Nuclear Medicine, Oncology +17